Hypoxia Promotes Angiogenic Effect in Extracranial Arteriovenous Malformation Endothelial Cells
Authors:
- Joon Seok LeeJLJoon Seok Lee
- Hyun Geun ChoHCHyun Geun Cho
- Jeong Yeop RyuJRJeong Yeop Ryu
- Eun Jung OhEOEun Jung Oh
- Hyun Mi KimHKHyun Mi Kim
- Suin KwakSKSuin Kwak
- Seok-Jong LeeSLSeok-Jong Lee
- Jongmin LeeJLJongmin Lee
- Sang Yub LeeSLSang Yub Lee
- Seung HuhSHSeung Huh
- Ji Yoon KimJKJi Yoon Kim
- Ho Yun ChungHCHo Yun Chung
Open Access
- 14 August 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (16) , 9109
Abstract
Arteriovenous malformation (AVM) is characterized by high-flow blood vessels connecting arteries and veins without capillaries. This disease shows increased angiogenesis and a pathophysiological hypoxic environment in proximal tissues. Here, we analyzed the effects of hypoxia on angiogenesis in the endothelial cells (ECs) of AVM and normal tissues. ECs from human normal and AVM tissues were evaluated using immunocytochemistry with CD31. In vitro tube formation under hypoxia was tested in both ECs using Matrigel. The relative expression of angiogenesis-related genes was measured using real-time PCR. Under normoxia, CD31 was significantly higher in AVM ECs (79.23 ± 0.65%) than in normal ECs (74.15 ± 0.70%). Similar results were observed under hypoxia in AVM ECs (63.85 ± 1.84%) and normal ECs (60.52 ± 0.51%). In the tube formation test under normoxic and hypoxic conditions, the junction count and total vessel length were significantly greater in AVM ECs than normal ECs. Under both normoxia and hypoxia, the angiogenesis-related gene FSTL1 showed a significantly higher expression in AVM ECs than in normal ECs. Under hypoxia, CSPG4 expression was significantly lower in AVM ECs than in normal ECs. Accordingly, the angiogenic effect was increased in AVM ECs compared with that in normal ECs. These results provide a basic knowledge for an AVM treatment strategy.Keywords
Funding Information
- Korean government (MSIT) (2020R1A2C2009496)
This publication has 34 references indexed in Scilit:
- Vascular Anomalies: From Genetics toward Models for Therapeutic TrialsCold Spring Harbor Perspectives in Medicine, 2012
- Increased Endothelial Progenitor Cells and Vasculogenic Factors in Higher-Staged Arteriovenous MalformationsPlastic and Reconstructive Surgery, 2011
- Follistatin-like 1, a Secreted Muscle Protein, Promotes Endothelial Cell Function and Revascularization in Ischemic Tissue through a Nitric-oxide Synthase-dependent MechanismJournal of Biological Chemistry, 2008
- Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasiaThorax, 2008
- Perivascular Cells Along Venules Upregulate NG2 Expression During Microvascular RemodelingMicrocirculation, 2006
- Differential Arterial/Venous Expression of NG2 Proteoglycan in Perivascular Cells Along Microvessels: Identifying a Venule‐Specific PhenotypeMicrocirculation, 2005
- Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow–derived cellsBlood, 2005
- Longitudinal Risk of Intracranial Hemorrhage in Patients With Arteriovenous Malformation of the Brain Within a Defined PopulationStroke, 2004
- Endothelial-Directed Hepatic Regeneration After Partial HepatectomyAnnals of Surgery, 2003
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994